Greg’s passion for improving health and following the evidence
Greg Fell brings public health passion and expertise to key role on the UK NSC.
Mike Harris
Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
Anne’s ethical principles forged in tandem careers
UK NSC's clinical ethicist members has tandem passions in work and leisure.
Graham excited by challenges facing the evolving UK NSC
Dr Graham Shortland OBE talks about his roles on the UK NSC as vice-chair and a paediatric specialist and the exciting challenges facing the committee.
Anneke helps the UK NSC navigate the complexities of genetics
Anneke helps the UK NSC navigate the complexities of clinical genetics evidence in screening when public expectations about the ability of genetics to predict ill health are running high.
English government endorses recommendation to screen newborns for tyrosinaemia
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
Screening research: who does what?
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
Consultation opens on modifying antenatal screening pathway for Edwards' syndrome
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
UK NSC explores potential developments in bowel cancer screening
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
UK NSC updates info on how commercial screening tests differ from NHS programmes
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
Minutes published of UK NSC’s November 2023 meeting
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.